Hugel Receives U.S. FDA Approval for Its Botulinum Toxin Letybo ...Middle East

PR Newswire - News
Hugel Receives U.S. FDA Approval for Its Botulinum Toxin Letybo
Hugel becomes the first and only Korean company that have market approvals in all three major aesthetic markets – U.S., Europe and China U.S. is the largest and fastest growing aesthetic market globally at USD 2.5 bn in 2023, and expected to nearly double to USD 4.9 bn by 2031 SEOUL,...

Hence then, the article about hugel receives u s fda approval for its botulinum toxin letybo was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Hugel Receives U.S. FDA Approval for Its Botulinum Toxin Letybo )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News